Product Information
HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML is a brand product labeled by AbbVie Inc., priced at $6745.4280 per EA under NDC 00074012403. Its NADAC has been published 123 times since Apr 17, 2024.
Manufacturer
AbbVie Inc.NDC
00074012403
Classification
Brand
Dosage Form
KIT
Effective Date
5/20/2026
Approval Type
Biologic (BLA)
FDA Application
BLA125057On Market Since
4/21/2017
Price Statistics
The NADAC for HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6745.4280 per EA |
|---|---|
| All-time high | $6745.4280 (Aug 19, 2026) |
| All-time low | $6692.6115 (Dec 18, 2024) |
| 52-week high | $6745.4280 |
| 52-week low | $6730.7909 |
| Median price | $6730.7909 |
| Average price | $6727.5863 |
| Largest weekly change | -0.6% (Dec 18, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML?
The current National Average Drug Acquisition Cost (NADAC) for HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML, manufactured by AbbVie Inc., is $6745.4280 per EA (NDC 00074012403), effective Aug 19, 2026.
How has the price of HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML changed over time?
Over the history we have for it, the NADAC for HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML?
Since Apr 17, 2024, the NADAC for HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML has ranged from a low of $6692.6115 (Dec 18, 2024) to a high of $6745.4280 (Aug 19, 2026), with a median of $6730.7909 per EA.
Are there cheaper alternatives to HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HUMIRA(CF) 20 MG/0.2 ML SYRINGE, is $3366.1230 per EA — about 50% below HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML.
Who manufactures HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML?
HUMIRA(CF) PEN CROHN'S-UC-HS STARTER 80 MG/0.8 ML (NDC 00074012403) is labeled by AbbVie Inc., and CMS classifies it as a brand product.